Cullgen (shanghai),inc
Clinical trials sponsored by Cullgen (shanghai),inc, explained in plain language.
-
New hope for tough blood cancers? early trial of CG009301 begins
Disease control Recruiting nowThis early-phase study tests a new drug called CG009301 in adults with blood cancers (like leukemia or MDS) that returned or didn't respond to standard treatments. The main goals are to find a safe dose and see if the drug can help control the disease. About 45 participants will …
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated May 26, 2026 11:59 UTC
-
New pill targets rare gene in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug, CG001419, in adults with advanced solid tumors that have a specific change in the NTRK gene. The goal is to find a safe dose and see if the drug can shrink tumors. About 42 people will take the drug by mouth until their cancer gets worse.
Phase: PHASE1, PHASE2 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated May 20, 2026 11:54 UTC